Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-07-17

FDA Approved: CETIRIZINE HYDROCHLORIDE — Supplemental Application (Rising Pharma Holdings, Inc.)

View source ↗

Summary

FDA approved a supplemental application for cetirizine hydrochloride submitted by Rising Pharma Holdings, Inc. The approval relates to changes in labeling for t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cetirizine hydrochloride (Cetirizine hydrochloride)

Snippet

SUPPL AP for CETIRIZINE HYDROCHLORIDE (CETIRIZINE HYDROCHLORIDE)